Status:
COMPLETED
Clinical Evaluation of Cordio App in Adult ADHF Patients
Lead Sponsor:
Cordio Medical
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Observational study on ADHF patients at one site in Israel. After signing informed consent and undergoing screening assessments, eligible patients will record sentences into a smartphone. The app will...
Eligibility Criteria
Inclusion
- Diagnosis of ADHF (pulmonary congestion)
- Known diagnosis of HF, with either preserved or reduced LVEF.
- 18+ years old.
- Able to understand and provide written informed consent.
Exclusion
- Subjects unable to comply with the daily use of the application due to mental disorders.
- GFR \<25 ml/min who are non-responsive to diuretic therapy or who are on chronic renal dialysis.
- Subjects with congenital heart disease or mechanical right heart valve(s).
- Airway and lung infection and Sepsis
- Patients with severe alcohol or drug use.
- Women who are pregnant or lactating.
Key Trial Info
Start Date :
May 24 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 10 2020
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT03266029
Start Date
May 24 2015
End Date
December 10 2020
Last Update
March 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Facility
Haifa, Israel